No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Innovation in the manufacturing of monoclonal antibodies can help reduce costs and make these therapeutics more accessible and affordable in LMICs. This grant will support the enhancement of the C1 ...

Dyadic International has secured a $3 million grant from the Bill & Melinda Gates Foundation to develop cost-effectiv ...

Dyadic international was awarded a $3 million grant from the Bill & Melinda Gates Foundation to fund the development of ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report.

Adagene Inc. (NASDAQ:ADAG – Get Free Report) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,500 shares, a ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

As we age, our muscles atrophy. Earlier this year, researchers found that hepatocyte growth factor (HGF), a protein critical in skeletal muscle development loses its functionality due to nitration as ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...